Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 6, 2016
[Response of BRAF(L597Q)-mutant melanoma to trametinib : Targeted melanoma therapy beyond BRAF(V600) mutations]O Haase, O Angün, V Grätz, et al.
The Journal of Investigative Dermatology|June 26, 1999
Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysisP Terheyden, C Siedel, A Merkel, et al.
The Journal of Investigative Dermatology|April 20, 2000
Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanomaC S Vetter, P T Straten, P Terheyden, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 27, 2001
[Nevus of Ota and choroid melanoma]P Terheyden, S Rickert, E Kämpgen, et al.
Scandinavian Journal of Immunology|November 25, 2003
Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progressionP Terheyden, D Schrama, L Ø Pedersen, et al.
Cancer Research|February 24, 2001
Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patientsD Schrama, M H Andersen, P Terheyden, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 17, 2008
[Spectroscopic imaging of the human liver using 3D CSI: optimization and application in patients with metastatic uvea melanoma]M Beer, V Winkelmann, J C Becker, et al.
British Journal of Cancer|October 10, 2002
Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2J C Becker, P Terheyden, E Kämpgen, et al.
Journal of Cancer Research and Clinical Oncology|March 6, 2007
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology GroupP Terheyden, A-K Kortüm, H-J Schulze, et al.
ESMO Open|October 29, 2021
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-upS P D'Angelo, S Bhatia, A S Brohl, et al.
Pageof 3